Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I studyJianliang Yang, Yuankai Shi, Jiarui Yao et al.|European Journal of Cancer|2020Cited by 70
A phase 1 trial of JS001, a monoclonal antibody targeting programmed death-1 (PD-1) in patients with advanced or recurrent malignancies.Sheng Yang, Yuankai Shi, Jianliang Yang et al.|Journal of Clinical Oncology|2017Cited by 2
A novel long-acting, follicle stimulating hormone-Fc fusion protein displays Gonal-f-like function in vitro and in vivoGuili Xu, Xin Gao, Cuima Yang et al.|Research Square|2021Cited by 0